Alaskan Ice CBD
White Widow-type × Haze-forward sativa × High-CBD donor (e.g., Cannatonic/ACDC-type)
Alaskan Ice (CBD) is a CBD-forward adaptation of the classic Alaskan Ice lineage, designed to offer clarity and functional relief with reduced intoxication. It retains the crisp, pine-menthol aroma and frosty appearance of its predecessor while providing a more balanced experience.
Appearance
This sativa-leaning cultivar typically exhibits a tall, upright structure with elongated internodes and long petioles. Many phenotypes display dense trichome coverage, contributing to a frosty, resinous appearance reminiscent of ice.
Aroma & Flavor
The name Alaskan Ice (CBD) evokes a crisp, pine-menthol profile. Many phenotypes express a bracing aroma and flavor that can include notes of pine, mint, and lemon. Subtle herbal undertones may also be present.
Effects
Tailored for users seeking clarity and calm, Alaskan Ice (CBD) aims for functional relief with minimal intoxication. It is noted for producing a steadier onset of effects compared to its THC-dominant ancestor, offering a sense of balance and relaxed comfort.
Terpenes & Cannabinoids
While specific lab results vary, CBD-leaning Alaskan Ice (CBD) cultivars often exhibit total terpene content between 1.0% and 3.0%. Common terpenes include pinene and terpinolene, contributing to the strain's brisk, conifer-forward bouquet. Cannabinoid profiles typically shift toward elevated CBDA and lower THCA compared to the original Alaskan Ice, with THC levels generally ranging from 10-30% and CBD below 1%.
Growing
Growers may encounter variability within the Alaskan Ice (CBD) family. The plant generally favors a sativa-leaning architecture. Achieving specific cannabinoid ratios often involves careful phenotype selection and potentially backcrossing over several generations to stabilize desired traits and disease resistance.
Origins & Lineage
Alaskan Ice (CBD) is a CBD-focused reinterpretation of the original Alaskan Ice, which emerged in the late 2000s. The CBD version was developed by crossing the original line with a high-CBD donor, aiming to preserve the crisp aromatics and appearance while moderating psychoactivity. This has resulted in a family of CBD-leaning chemovars rather than a single standardized cultivar.